Back

Antithrombotic treatment after TAVI in patients with CAD: what matters most valve or atherosclerosis .

30 August 2021 (08:33 - 08:45)
Organised by:
Congress Presentation Part of: Antithrombotic therapy after TAVI Interventional Cardiology ESC Premium Access ESC Congress 2021 - The Digital Experience

3 More presentations in this session

Presentation thumbnail
Antithrombotic treatment and valve-related outcomes (GALILEO 4D, ATLANTIS 4D): do they matter .
Slides Video
Presentation thumbnail
Antithrombotic treatment after TAVI in patients without indication for anticoagulation: anything else than aspirin.
Slides Video
Presentation thumbnail
Antithrombotic treatment after TAVI in patients with indication for anticoagulation.
Slides Video

Access the full session

Session thumbnail
Antithrombotic therapy after TAVI
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

30 August 2021 08:33 CET
You may be interested in
thumbnail
Congress Presentation
Antithrombotic therapy during TAVI and peri-interventional management of antithrombotic therapy.
28 August 2022
thumbnail
Congress Presentation
Cardiovascular risk and coronary artery disease burden in TAVI patients
29 June 2021
thumbnail
Congress Presentation
Meta-analysis of clinical trials comparing triple versus dual antithrombotic therapy on risk reduction of stent thrombosis after percutaneous coronary intervention in atrial fibrillation patients
27 August 2021
thumbnail
Webinar
Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients
19 July 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources